Mathias Schneeweiss-Gleixner

Pathophysiological mechanisms of liver injury in COVID‐19

M. Trauner, E. D. Dixon, S. Lax, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease

A. Ba-Ssalamah, M. Trauner, E. Halilbasic, 2022, Hepatology.

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells

G. Stefanzl, P. Valent, W. Sperr, 2022, Cancers.

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML

T. Lion, G. Stefanzl, M. Deininger, 2019, EBioMedicine.

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations.

T. Lion, G. Stefanzl, P. Valent, 2021, American journal of cancer research.

Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal

S. Galli, R. Moriggl, K. Sotlar, 2021, Frontiers in Veterinary Science.